Faricimab demonstrated a greater reduction in hard exudates than aflibercept in patients with diabetic macular edema (DME), according to research presented at EURETINA 2024. Hard exudates may be a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback